1. Home
  2. BWMN vs CSTL Comparison

BWMN vs CSTL Comparison

Compare BWMN & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowman Consulting Group Ltd.

BWMN

Bowman Consulting Group Ltd.

HOLD

Current Price

$35.87

Market Cap

579.7M

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.02

Market Cap

661.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWMN
CSTL
Founded
1995
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
579.7M
661.7M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
BWMN
CSTL
Price
$35.87
$39.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$41.13
$40.67
AVG Volume (30 Days)
133.5K
461.5K
Earning Date
11-05-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.94
N/A
Revenue
$474,277,000.00
$343,530,000.00
Revenue This Year
$16.97
$1.69
Revenue Next Year
$5.00
N/A
P/E Ratio
$38.71
N/A
Revenue Growth
16.73
10.15
52 Week Low
$17.90
$14.59
52 Week High
$45.83
$40.61

Technical Indicators

Market Signals
Indicator
BWMN
CSTL
Relative Strength Index (RSI) 51.14 69.78
Support Level $33.15 $36.63
Resistance Level $36.39 $40.54
Average True Range (ATR) 1.66 1.31
MACD 0.48 -0.48
Stochastic Oscillator 77.42 60.55

Price Performance

Historical Comparison
BWMN
CSTL

About BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: